Alcaftadine Synthesis via Formaldehyde Addition and Oxidation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for preparing Alcaftadine, an H1 histamine receptor antagonist, face challenges such as low yield, lengthy reaction times, and the risk of impurity formation due to cumbersome protection and deprotection processes, particularly in introducing the hydroxymethyl group.

Innovation Solution

A process involving the reaction of the acid addition salt of formula 7 with formaldehyde, followed by oxidation, which reduces reaction steps and time, and uses di-carboxylic acids like fumaric or succinic acid to enhance yield and purity, eliminating the need for ethyl carboxylate protection and minimizing impurity formation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If the conventional process using ethyl carboxylate protection is used, then the hydroxymethyl group can be introduced, but the process requires cumbersome protection and deprotection steps resulting in low yield

Engineering Contradiction:
Improvepurity of AlcaftadineVSAvoidyield of Alcaftadine
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The invention removes the ethyl carboxylate protection step entirely from the synthesis pathway. By using a different chemical approach to introduce the hydroxymethyl group directly onto the intermediate compound, the patent eliminates the need for protective group chemistry, thereby removing both the protection and deprotection steps that were causing yield loss.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

Instead of protecting the carboxyl group before introducing the hydroxymethyl group (conventional approach), the invention inverts the sequence by introducing the hydroxymethyl group first and then handling the carboxyl group differently. This reversal of the synthetic strategy eliminates the need for ethyl carboxylate protection while achieving the same chemical transformation.

Inventive Principle:
Principle #13The other way round (Inversion)

2Manufacturing precision

If the conventional process is used, then the hydroxymethyl group can be introduced, but it requires multiple reaction steps resulting in low overall yield

Engineering Contradiction:
Improvepurity of AlcaftadineVSAvoidnumber of reaction steps
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The invention merges multiple separate operations into a more integrated process. By combining the hydroxymethyl introduction step with a streamlined approach to handling the carboxyl group, the patent reduces the number of discrete reaction steps from multiple protection/deprotection cycles to a more direct transformation sequence.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention performs preliminary chemical modifications to the intermediate compound that enable subsequent steps to proceed more efficiently. By pre-positioning functional groups or modifying the molecular structure in advance, the patent eliminates the need for later protection/deprotection maneuvers, reducing overall process complexity.

Inventive Principle:
Principle #10Preliminary action

3Productivity

If formaldehyde is used to introduce the hydroxymethyl group, then the reaction can proceed, but long reaction times increase the risk of dihydroxymethyl impurity formation

Engineering Contradiction:
Improveyield of AlcaftadineVSAvoidpurity of Alcaftadine
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention changes key reaction parameters including temperature, solvent system, catalyst selection, and formaldehyde equivalent usage. By optimizing these parameters, the patent accelerates the hydroxymethyl introduction reaction to complete within a shorter time frame, thereby minimizing the window for side reactions that would produce dihydroxymethyl impurities.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses a controlled excess of formaldehyde (22 equivalents) but limits the reaction time to less than one week. This approach ensures complete conversion to the desired hydroxymethyl product while preventing over-reaction that would lead to dihydroxymethyl formation. The partial action principle is applied by stopping the reaction at the optimal point before impurity accumulation occurs.

Inventive Principle:
Principle #16Partial or excessive action

4Productivity

If the reaction time is extended to ensure complete conversion, then yield may improve, but the risk of obtaining dihydroxymethyl impurity increases

Engineering Contradiction:
Improveyield of AlcaftadineVSAvoidpurity of Alcaftadine
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The invention implements process monitoring and control mechanisms that allow real-time assessment of reaction progress. By using analytical methods to track the consumption of starting material and formation of product, the patent can determine the optimal endpoint of the reaction, ensuring complete conversion to the desired product while stopping before dihydroxymethyl impurities accumulate to significant levels.

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process significantly increases the yield and purity of Alcaftadine, achieving greater than 99% purity through careful solvent selection and crystallization, while reducing the risk of secondary hydroxymethyl group introduction.

Implementation Method 1

reacting the acid addition salt of formula 7 with formaldehyde to the compound of formula 11

Methodology Applied
Scientific EffectNucleophilic addition:

Implementation Method 2

oxidizing the compound of formula 11 to Alcaftadine

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 3

converting Alcaftadine to a pharmaceutically acceptable salt thereof

Methodology Applied
Scientific EffectAcid-base reaction:

Implementation Method 4

crystallization in isopropyl alcohol or ethyl acetate

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Data Source

PatentEP2978765B1Methods for the preparation of alcaftadine
Publication Date: 2018.05.02 CRYSTAL PHARMA SA
  • EP2978765B1 patent drawing
  • EP2978765B1 patent drawing
  • EP2978765B1 patent drawing

AI summary

The invention relates to new and improved processes for the preparation of Alcaftadine and pharmaceutically acceptable salts thereof as well as an intermediate for the preparation of Alcaftadine. The new process saves a number of steps compared to the known process and results in a higher yield.